GlassScriptPhysician profile
John P Kern
NPI 1598366155
$9,645.17
in general payments reported to CMS, 2019-2025
56 companies · $2,168 in 2025
The $2,168 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,840 · 2022: $1,809 · 2023: $1,979 · 2024: $1,850 · 2025: $2,168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,879 · Education: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,879.43 |
| Education | $117.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,803.89 | 2021-2025 | |
| Novo Nordisk INC | $1,298.83 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $779.21 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Lilly USA, LLC | $525.03 | 2021-2025 | Zepbound, Mounjaro, Jardiance |
| Glaxosmithkline, LLC. | $508.35 | 2021-2025 | Trelegy Ellipta, Nucala, Shingrix |
| Takeda Pharmaceuticals U.S.A., INC. | $427.42 | 2021-2024 | Trintellix |
| Astellas Pharma US INC | $370.17 | 2021-2025 | Veozah, Myrbetriq |
| Otsuka America Pharmaceutical, INC. | $335.00 | 2022-2025 | Rexulti |
| Pfizer INC. | $310.36 | 2023-2025 | |
| Corium, LLC | $293.41 | 2022-2025 | Azstarys |
| Amgen INC. | $284.69 | 2021-2025 | Repatha, Otezla, Evenity |
| Janssen Pharmaceuticals, INC | $197.67 | 2021-2022 | |
| Esperion Therapeutics, INC. | $184.99 | 2021-2025 | Nexletol |
| Novartis Pharmaceuticals Corporation | $170.60 | 2021-2024 | |
| Ironwood Pharmaceuticals, INC | $165.75 | 2021-2024 | Linzess |
Show all 56 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kern listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.